1-Piperonylpiperazine
1-Piperonylpiperazine (MDBP) is metabolized by demethylenation and subsequent methylation to N- (4-hydroxy-3-methoxybenzyl) piperazine followedby partial glucuronidation or sulfation. 1-Piperonylpiperazine can alter the disposition and metabolism of 3,4-methylenedioxymethamphetamine (MDMA) in the brain and in peripheral organs. 1-Piperonylpiperazine can inhibit the MDMA-induced neurotoxicity[1].
Product Specifications
CAS Number
32231-06-4
Product Name Alternative
MDBP
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Biochemical Assay Reagents
Related Pathways
Others
Field of Research
Neurological Disease
Purity
99.56
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
C1(CN2CCNCC2)=CC3=C(OCO3)C=C1
Molecular Formula
C12H16N2O2
Molecular Weight
220.27
Precautions
H315, H319, H335
References & Citations
[1]Staack, R. F., & Maurer, H. H. (2004) . New designer drug 1- (3,4-methylenedioxybenzyl) piperazine (MDBP) : studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry. Journal of mass spectrometry : JMS, 39 (3), 255–261.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound2
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
